Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan;69(1):420-430.
doi: 10.1002/hep.30150. Epub 2018 Dec 27.

Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances

Keisaku Sato  1   2   3 , Marco Marzioni  4 , Fanyin Meng  1   3   5 , Heather Francis  1   2   3 , Shannon Glaser  1   2   3 , Gianfranco Alpini  1   2   3
Affiliations
Review

Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances

Keisaku Sato et al. Hepatology. 2019 Jan.

Erratum in

  • Correction.
    [No authors listed] [No authors listed] Hepatology. 2019 Sep;70(3):1089. doi: 10.1002/hep.30878. Epub 2019 Aug 5. Hepatology. 2019. PMID: 31472030 No abstract available.

Abstract

Ductular reaction (DR) is characterized by the proliferation of reactive bile ducts induced by liver injuries. DR is pathologically recognized as bile duct hyperplasia and is commonly observed in biliary disorders. It can also be identified in various liver disorders including nonalcoholic fatty liver disease. DR is associated with liver fibrosis and damage, and the extent of DR parallels to patient mortality. DR raises scientific interests because it is associated with transdifferentiation of liver cells and may play an important role in hepatic regeneration. The origin of active cells during DR can be cholangiocytes, hepatocytes, or hepatic progenitor cells, and associated signaling pathways could differ depending on the specific liver injury or animal models used in the study. Although further studies are needed to elucidate detailed mechanisms and the functional roles in liver diseases, DR can be a therapeutic target to inhibit liver fibrosis and to promote liver regeneration. This review summarizes previous studies of DR identified in patients and animal models as well as currently understood mechanisms of DR.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1. Location of cholangiocytes, HPCs, and hepatocytes in the liver
Identified markers for these cells are shown in green, red, and orange, respectively.
Figure 2
Figure 2. Types of DR
During cholangiocyte damage, cholangiocytes and/or HPCs proliferate to compensate biliary cell population and functions. Hepatocytes transdifferentiate into cholangiocytes and/or biliary-like cells that have different gene expression profiles. During hepatocyte damage, cholangiocytes start proliferation and transdifferentiate into hepatocytes via HPCs. The types of DR and the origin of active cells vary depending on liver injuries or experimental conditions.
Figure 3
Figure 3
Pathways of DR-associated transdifferentiation. Hippo/YAP/Notch signaling as well as HGF/c-Met signaling are associated with transdifferentiation into cholangiocytes, and Wnt/β-catenin signaling is associated with transdifferentiation into hepatocytes. Expression levels of stem cell or oval cell markers such as A6 and OV6 are elevated during this process. Although TWEAK/Fn14 signaling induces HPC and/or cholangiocyte proliferation, it is unclear whether this signaling is required for transdifferentiation of liver cells. It is also unclear whether hepatocytes and/or cholangiocytes transdifferentiate directly or via HPCs. Previous studies indicate senescent hepatocytes may trigger transdifferentiation leading to DR and liver regeneration.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P, Brunt EM, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology. 2004;39:1739–1745. - PubMed
    1. Gadd VL, Skoien R, Powell EE, Fagan KJ, Winterford C, Horsfall L, Irvine K, et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology. 2014;59:1393–1405. - PubMed
    1. Lorenzini S, Bird TG, Boulter L, Bellamy C, Samuel K, Aucott R, Clayton E, et al. Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. Gut. 2010;59:645–654. - PMC - PubMed
    1. Gouw AS, van den Heuvel MC, Boot M, Slooff MJ, Poppema S, de Jong KP. Dynamics of the vascular profile of the finer branches of the biliary tree in normal and diseased human livers. J Hepatol. 2006;45:393–400. - PubMed
    1. Sackett SD, Li Z, Hurtt R, Gao Y, Wells RG, Brondell K, Kaestner KH, et al. Foxl1 is a marker of bipotential hepatic progenitor cells in mice. Hepatology. 2009;49:920–929. - PMC - PubMed

Publication types